
The findings of a new study show that patients with a history of coronary artery disease who undergo metabolic surgery are approximately two times less likely to suffer a recurrent and fatal heart attack or develop systolic heart failure. The study was presented at the 36th American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting at ObesityWeek 2019.
To conduct this study, the researchers assessed cardiovascular outcomes among approximately 8,200 metabolic surgery patients and compared them to the outcomes of more than 79,000 nonsurgical patients with a history of heart disease and severe obesity. Almost half of the metabolic surgery patients had a history of diabetes, more than 70% had hypertension, while the nonsurgical patients exhibited higher instances of both diseases.